Inventor · disambiguated record
Casey Cameron Mccomas
Also filed as: MCCOMAS CASEY · MCCOMAS CASEY C · MCCOMAS CASEY CAMERON
42 granted patents·24 pending applications·176 citations·filing 2005–2024
97Inventor score
Files withWYETH CORP19CYTEIR THERAPEUTICS INC15WYETH LLC9MERCK SHARP & DOHME8ACURX PHARMACEUTICALS LLC4
Top patents by PatentIndex Score
66 records- 0197US7317037B2Progesterone receptor modulators comprising pyrrole-oxindole derivatives and uses thereofWYETH CORP·Filed 2005·Granted Jan 8, 2008·69 cites·37 claims
- 0295US11084812B2RAD51 inhibitorsCYTEIR THERAPEUTICS INC·Filed 2020·Granted Aug 10, 2021·4 cites·23 claims
- 0394US10336746B1RAD51 inhibitorsCYTEIR THERAPEUTICS INC·Filed 2018·Granted Jul 2, 2019·7 cites·4 claims
- 0493US10590122B2RAD51 inhibitorsCYTEIR THERAPEUTICS INC·Filed 2018·Granted Mar 17, 2020·7 cites·19 claims
- 0591US9364482B2Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseasesMERCK SHARP & DOHME·Filed 2014·Granted Jun 14, 2016·8 cites·15 claims
- 0690US11247988B2RAD51 inhibitorsCYTEIR THERAPEUTICS INC·Filed 2020·Granted Feb 15, 2022·2 cites·33 claims
- 0789US11607404B2Combinations of RAD51 and PARP inhibitorsCYTEIR THERAPEUTICS INC·Filed 2020·Granted Mar 21, 2023·3 cites·12 claims
- 0888US9265773B2Tetracyclic heterocycle compounds and methods of use thereof for the treatment of viral diseasesMCCOMAS CASEY C·Filed 2012·Granted Feb 23, 2016·8 cites·15 claims
- 0986US9815846B2TrkA kinase inhibitors, compositions and methods thereofMERCK SHARP & DOHME·Filed 2015·Granted Nov 14, 2017·8 cites·16 claims
- 1086US7517899B2Phenylaminopropanol derivatives and methods of their useWYETH CORP·Filed 2005·Granted Apr 14, 2009·9 cites·28 claims
- 1186US7297713B2Cyanopyrrole-phenyl amide progesterone receptor modulators and uses thereofWYETH CORP·Filed 2006·Granted Nov 20, 2007·8 cites·18 claims
- 1286US2025136591A1Rad51 inhibitorsCYTEIR THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1385US7618990B2Oxazolidone derivatives as PR modulatorsWYETH CORP·Filed 2007·Granted Nov 17, 2009·9 cites·24 claims
- 1485US7291643B2Cyanopyrrole-sulfonamide progesterone receptor modulators and uses thereofWYETH CORP·Filed 2006·Granted Nov 6, 2007·8 cites·20 claims
- 1582US9242998B2Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis CHE SHUWEN·Filed 2014·Granted Jan 26, 2016·8 cites·17 claims
- 1680US11291655B2RAD51 inhibitorsCYTEIR THERAPEUTICS INC·Filed 2018·Granted Apr 5, 2022·1 cites·20 claims
- 1780US9573939B2Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseasesMCCOMAS CASEY C·Filed 2012·Granted Feb 21, 2017·6 cites·6 claims
- 1880US2024360120A1Rad51 inhibitorsCYTEIR THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1979US9273033B2Substituted pyridone derivatives as PDE10 inhibitorsMERCK SHARP & DOHME·Filed 2013·Granted Mar 1, 2016·2 cites·17 claims
- 2077US7750038B2Sulfonylated heterocycles useful for modulation of the progesterone receptorWYETH LLC·Filed 2008·Granted Jul 6, 2010·2 cites·17 claims
- 2176US7601722B2Aryl sulfamide derivatives and methods of their useWYETH CORP·Filed 2007·Granted Oct 13, 2009·2 cites·58 claims
- 2274US9353104B2Substituted pyridizinone derivatives as PDE10 inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted May 31, 2016·2 cites·16 claims
- 2374US7723332B2Aryl sulfonamides useful for modulation of the progesterone receptorWYETH LLC·Filed 2008·Granted May 25, 2010·1 cites·13 claims
- 2473US2022056022A1Rad51 inhibitorsCYTEIR THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2572US11932636B2RAD51 inhibitorsCYTEIR THERAPEUTICS INC·Filed 2021·Granted Mar 19, 2024·0 cites·25 claims
- 2672US2025082614A1Methods of using rad51 inhibitors for treatment of pancreatic cancerCYTEIR THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2769US10723741B1DNA polymerase IIIC inhibitors and use thereofACURX PHARMACEUTICALS LLC·Filed 2019·Granted Jul 28, 2020·0 cites·11 claims
- 2869US10059718B2Fused quadracyclic compounds, compositions and uses thereofTABOMEDEX BIOSCIENCES LLC·Filed 2017·Granted Aug 28, 2018·1 cites·27 claims
- 2969US2022112195A1DNA Polymerase IIIC Inhibitors and Use ThereofACURX PHARMACEUTICALS LLC·Filed 2021·Application pending·0 cites
- 3068US11001592B2DNA polymerase IIIC inhibitors and use thereofACURX PHARMACEUTICALS LLC·Filed 2020·Granted May 11, 2021·0 cites·17 claims
- 3167US10836772B2DNA polymerase IIIC inhibitors and use thereofACURX PHARMACEUTICALS LLC·Filed 2020·Granted Nov 17, 2020·0 cites·6 claims
- 3267US9549917B2Heterocyclic-substituted benzofuran derivatives and methods of use thereof for the treatment of viral diseasesMCCOMAS CASEY C·Filed 2012·Granted Jan 24, 2017·1 cites·14 claims
- 3363US2025170112A1Adenosine ligands for the treatment of neurological disordersLUCY THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3462US12064419B2Methods of using RAD51 inhibitors for treatment of pancreatic cancerCYTEIR THERAPEUTICS INC·Filed 2020·Granted Aug 20, 2024·0 cites·16 claims
- 3562US2009093469A1Phenylaminopropanol Derivatives and Methods of Their UseWYETH CORP·Filed 2008·Application pending·0 cites
- 3662US2009099164A1Phenylaminopropanol Derivatives and Methods of Their UseWYETH CORP·Filed 2008·Application pending·0 cites
- 3761US2025136606A1Modulators of trpml, their compositions and methods of useCARAWAY THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3861US2024398812A1Modulators of trpml, their compositions and methods of useCARAWAY THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3960US2025186404A1Methods of using a (thiazolyl)benzenesulfonamide derivativeCYTEIR THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4060US2025276952A14-aminophenyl-thiazole derivatives and methods of use thereofCYTEIR THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4160US2010029641A1Aryl sulfamide derivatives and methods of their useWYETH CORP·Filed 2009·Application pending·0 cites
- 4259US2025268869A1Methods of using a (thiazolyl)benzenesulfonamide derivativeCYTEIR THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4357US7652062B2Cyanopyrrole-phenyl amide progesterone receptor modulators and uses thereofWYETH LLC·Filed 2007·Granted Jan 26, 2010·0 cites·15 claims
- 4456US2008114050A1Progesterone receptor modulators comprising pyrrole-oxindole derivatives and uses thereofWYETH CORP·Filed 2007·Application pending·0 cites
- 4554US9284302B2Cyclobutyl benzimidazoles as PDE 10 inhibitorsMERCK SHARP & DOHME·Filed 2013·Granted Mar 15, 2016·0 cites·17 claims
- 4651US9549921B2Heterocyclic compounds and methods of use thereof for the treatment of hepatitis CHE SHUWEN·Filed 2014·Granted Jan 24, 2017·0 cites·17 claims
- 4749US10562909B2Fused quadracyclic compounds, compositions and uses thereofTABOMEDEX BIOSCIENCES LLC·Filed 2018·Granted Feb 18, 2020·0 cites·34 claims
- 4849US7718652B2Substituted benzothiadiazinedioxide derivatives and methods of their useWYETH LLC·Filed 2007·Granted May 18, 2010·0 cites·68 claims
- 4949US7538107B2Oxazinan-2-one derivatives useful as PR modulatorsWYETH CORP·Filed 2007·Granted May 26, 2009·0 cites·22 claims
- 5048US7652018B2Imidazolidin-2-one derivatives useful as PR modulatorsWYETH LLC·Filed 2007·Granted Jan 26, 2010·0 cites·17 claims
Showing the top 50 of 66 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →